LTA4H and colorectal carcinoma: The elevated levels of LTA4H were found significantly correlated with an increased risk of CRC with an OR of 2.55 (95% CI: 1.30–5.02) and 7.40 (95% CI: 2.11–25.93) in the discovery and validation set, respectively.